Search Results 1651-1660 of 17007 for Green Birth Control

1. Characterization of Biliary Cell-derived Organoids from Bile of PSC and Non-PSC Patients - Mayo Clinic

   Patients with PSC and Cholangiocarcinoma will be included. Controls. Controls without history of PSC or evidence of other chronic liver disease of either ...

2. Prevalence of Hypervigilant Eating Habits in Pediatric Patients With Gastrointestinal Symptoms - Mayo Clinic

   ... controls. Also, to survey the quality of life of these patients as it ... Group B (control group) will include patients ages 6 and up presenting to ...

3. A Study of Molecular Characterization of Spinal Tissue - Mayo Clinic

   The purpose of this study is to identify molecular mechanisms that control spine deformity and degenerative changes that can be used for therapeutic strategies.

4. Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - Mayo Clinic

   Requires second line treatments (eg, telotristat) for control of carcinoid syndrome symptoms in the opinion of the Investigator. Treatment with specific NET ...

5. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

   The purpose of this study is to determine if Regorafenib improves overall survival in refractory AGEC A randomized phase III, double-blind, placebo-controlled ...

6. Clinical Trials - A Study to Evaluate MR of CSF Dynamics

   ... controls, as well as patients with other dementia disorders. ... A healthy control will be defined as an otherwise healthy person who does ...

7. Expanded Hereditary Cancer Genetic Testing - Mayo Clinic

   ... management as well as those for whom new clinical management options exist). Participation eligibility. Participant eligibility includes age, gender, type ...

8. The Effects of Acute and Chronic Exercise on the Immune Phenotype in Healthy Patients - Mayo Clinic

   Exclusion criteria. Healthy Controls. Subjects will be excluded if they have cardiovascular or pulmonary disease or autoimmune diseases. A pregnancy test will ...

9. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

   This is a single-arm Simon II stage design, multicenter study consisting of a screening period, an induction treatment period (2 cycles of blinatumomab), a ...

10. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

    Grade 3 a fib defined as symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker); or ablation and; Patients with ...